Myeloproliferative disorders and the hyperviscosity syndrome

Emerg Med Clin North Am. 2009 Aug;27(3):459-76. doi: 10.1016/j.emc.2009.04.001.

Abstract

Myeloproliferative disorders and the serum hyperviscosity syndrome can rapidly manifest with emergent presentations. Hyperviscosity occurs from pathologic elevations of either the cellular or acellular (protein) fractions of the circulating blood. Classic hyperviscosity syndrome presents with the triad of bleeding diathesis, visual disturbances and focal neurologic signs. Emergency medicine providers should be aware of these conditions and be prepared to rapidly initiate supportive and early definitive management, including plasma exchange and apharesis. Early consultation with a hematologist is essential to managing these complex patients.

Publication types

  • Review

MeSH terms

  • Blood Proteins / metabolism
  • Blood Viscosity / physiology*
  • Humans
  • Leukocytosis / diagnosis
  • Leukocytosis / physiopathology
  • Leukocytosis / therapy
  • Myeloproliferative Disorders / diagnosis*
  • Myeloproliferative Disorders / physiopathology
  • Myeloproliferative Disorders / therapy*
  • Plasma Exchange
  • Plasmapheresis
  • Polycythemia / diagnosis
  • Polycythemia / physiopathology
  • Polycythemia / therapy
  • Syndrome

Substances

  • Blood Proteins